Sale of Bertin Pharma’s pharmaceutical development activities to Amatsigroup
|Client||CNIM is a French industrial engineering contractor and equipment manufacturer that operates in the sector of Environment, Energy, Defense and High Technologies|
|Sector||Healthcare – CDMO|
|Deal||Sale of Bertin Pharma’s pharmaceutical development activities to Amatsigroup (Eurofins)|
What we did:
Capitalmind actively supported CNIM Group along the sell-side process: marketing materials preparation, screening and selection of the relevant strategic buyers through a competitive process, valuation guidance, management of carve-out considerations, management of the due diligences, negotiation of terms and conditions of the deal, etc.